Virus and Antibody Dynamics in Acute West Nile Virus Infection
Top Cited Papers
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (7) , 984-993
- https://doi.org/10.1086/591467
Abstract
The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for >40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for >40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for >40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.Keywords
This publication has 35 references indexed in Scilit:
- Interferon and Interferon-Induced Chemokine Expression Is Associated with Control of Acute Viremia in West Nile Virus-Infected Blood DonorsThe Journal of Infectious Diseases, 2008
- Comprehensive Analysis of West Nile Virus–Specific T Cell Responses in HumansThe Journal of Infectious Diseases, 2008
- Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon ProductionJournal of Virology, 2007
- Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent MechanismsPLoS Pathogens, 2007
- Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus InfectionJournal of Virology, 2006
- Self‐reported symptoms associated with West Nile virus infection in RNA‐positive blood donorsTransfusion, 2005
- Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003Transfusion, 2005
- Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision makingTransfusion, 2004
- Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United StatesClinical and Vaccine Immunology, 2003
- Use of Immunoglobulin M Cross-Reactions in Differential Diagnosis of Human Flaviviral Encephalitis Infections in the United StatesClinical and Vaccine Immunology, 2002